-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gastrointestinal pathological α-synaptic protein deposition and the existence of constipation in the precursor and clinical establishment of Parkinson's disease (PD) indicate that the intestinal-brain axis plays an indispensable role in the early pathogenesis of PD
.
It is speculated that synaptopathies rise from peripheral neurons of the gastrointestinal tract to the brain through the vagus nerve
In addition, the increased intestinal permeability, increased fecal inflammatory cytokines, and inflammation of the colon wall in PD patients have been proven, which may also represent the key gastrointestinal process of the precursor PD
.
Mice overexpressing α-synuclein showed increased motor dysfunction after being colonized by the gut microbiota of PD patients
Mice overexpressing α-synuclein showed increased motor dysfunction after being colonized by the gut microbiota of PD patients
Based on these evidences, it is possible to define specific predictive values for these markers, and calculate the probability of individual precursor PD based on age and marker conditions
.
Several markers of pre-PD established in the research standards of the International Parkinson and Dyskinesia Society (MDS) are also related to changes in intestinal microbes by age and the International Society for Parkinson and Movement Disorders (MDS); these markers include risk markers such as men, diabetes , non-smokers and non-use Caffeine and precursor markers such as RBD, constipation, and depression
These markers include risk markers such as men, diabetes , non-smokers and non-caffeine use, and prodrome markers such as RBD, constipation, and depression
In this way, Sebastian Heinzel and others of the University of Kiel in Germany evaluated the diversity, intestinal type and taxonomic composition of gut microbes, and investigated their relationship with a comprehensive set of PD risk and precursor markers, overall precursor PD probability and a large number of The relationship between other potential confounding factors
.
.
And investigated their relationship with a comprehensive set of PD risk and precursor markers, overall precursor PD probability, and a large number of other potential confounding factors
They found that among the risk and prodrome markers, non-exercise, occupational solvent exposure, and constipation were associated with α-diversity
.
Insufficient physical activity, gender, constipation, possible REM-sleep behavior disorder (RBD), and smoking are related to β-diversity
.
Subliminal Parkinson's disease and insufficient physical activity show an interactive effect
Among other factors, age and uric acid lowering drugs are related to α- and β-diversity
.
Constipation is highest in individuals with intestinal types rich in Firmicutes, while non-exercise is most common in intestinal types rich in Bacteroides
.
Pu Lei Wote coli enrichment of individuals constipation lowest rate, the lowest incidence of sub-threshold Parkinson's disease
Individuals enriched with Revotella have the lowest constipation rate and the lowest incidence of subthreshold Parkinson's disease
The important significance of this study is that some risk and precursor markers of PD were found to be related to the composition of the gut microbiome
.
However, the impact of the gut microbiome on the risk of PD and the potential microbiome-dependent subtypes in PD prodromal symptoms need to be further explored.
Of course, this requires prospective clinical and (multi) global data based on incident PD cases
.
Original source:
Heinzel S, Aho VTE, Suenkel U, von Thaler AK, Schulte C, Deuschle C, Paulin L, Hantunen S, Brockmann K, Eschweiler GW, Maetzler W, Berg D, Auvinen P, Scheperjans F.
Gut microbiome signatures of risk and prodromal markers of Parkinson's disease.
Ann Neurol.
2021 May 22.
doi: 10.
1002/ana.
26128.
Epub ahead of print.
PMID: 34021620.